SDI25 Abstract Submission
Welcome to the SDI25 Abstract Submission Page. SalivaDirect, Inc. invites abstract submissions for our 4th Annual Conference (June 3-6, 2025). Submit your abstract below for an opportunity to join industry leaders and change-makers taking our virtual stage this June. 
  • Submission Deadline: May 2, 2025 
  • Maximum length: 300 words (2000 characters)
  • There is no limit to the number of abstracts an author can submit. 
  • Abstract disposition notices will be sent via email to the presenting author by May 16, 2025.
SDI welcomes abstract submissions concerning saliva, infectious diseases, case studies and reports on testing programs, innovations in laboratory methods, and adjacent topics. Abstracts will be selected on the basis of their scientific merit, timeliness, significance, and adherence to our requirements below. Authors of accepted abstracts will either be invited for a virtual oral presentation of their research or for participation in a virtual poster session.
Sign in to Google to save your progress. Learn more
Your email *
Your first name *
Your last name *
Your institution *
Preferred type of presentation  *
Abstract title 
Submit your title in ALL CAPS
*
Presenting author name 
Submit using the format: First name, Middle Initial if applicable, Last name
*
Presenting author affiliation
*
Author list
Submit using the format as follows:
First name, Middle Initial if applicable, Last name (number of affiliation) [Eg: John C Smith (1), Mary J Andrews (2)]
*
Author affiliations 
Submit using the format as follows:
(1) Department, Institution, Country.
(2) Department, Institution, Country, etc
*

Abstract (max 300 words/2000 characters)

Please submit a structured abstract under the following section headings: Background, Methods, Results, Conclusion

*
Is your registration for the conference dependent on the outcome of your submitted abstract?
*
Additional comments or questions 
Submit
Clear form
Never submit passwords through Google Forms.
This form was created inside of SalivaDirect Inc.

Does this form look suspicious? Report